ImportRefusal LogoImportRefusal

Laboratoire Bioderma

⚠️ Moderate Risk

FEI: 3002679824 • Lyon, Rhone • FRANCE

FEI

FEI Number

3002679824

📍

Location

Lyon, Rhone

🇫🇷

Country

FRANCE
🏢

Address

75 Cours Albert Thomas, , Lyon, Rhone, France

Moderate Risk

FDA Import Risk Assessment

35.0
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

9
Total Refusals
6
Unique Violations
7/23/2010
Latest Refusal
6/2/2004
Earliest Refusal

Score Breakdown

Violation Severity
56.1×40%
Refusal Volume
37.0×30%
Recency
0.0×20%
Frequency
14.7×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

165×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

1183×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

4722×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

4711×

CSTIC LBLG

The labeling appears to fail to comply with cosmetic labeling requirements of Section 602(a), and/or (b), and/or (c), and as identified by 21 C.F.R. Part 701.

4751×

COSMETLBLG

It appears that the cosmetic consists of two or more ingredients and the label does not list the common or usual name of each ingredient.

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
7/23/2010
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
472NO ENGLISH
75UNAPPROVED
Philadelphia District Office (PHI-DO)
7/23/2010
66PBY99ULTRAVIOLET SCREEN/SUNSCREEN N.E.C.
118NOT LISTED
16DIRECTIONS
472NO ENGLISH
Philadelphia District Office (PHI-DO)
5/12/2010
66PBY99ULTRAVIOLET SCREEN/SUNSCREEN N.E.C.
16DIRECTIONS
Philadelphia District Office (PHI-DO)
5/12/2010
66PBY99ULTRAVIOLET SCREEN/SUNSCREEN N.E.C.
16DIRECTIONS
Philadelphia District Office (PHI-DO)
5/12/2010
66PBY99ULTRAVIOLET SCREEN/SUNSCREEN N.E.C.
16DIRECTIONS
Philadelphia District Office (PHI-DO)
5/12/2010
66PBY99ULTRAVIOLET SCREEN/SUNSCREEN N.E.C.
16DIRECTIONS
Philadelphia District Office (PHI-DO)
6/2/2004
53LD99OTHER SKIN CARE PREPARATIONS, N.E.C.
471CSTIC LBLG
475COSMETLBLG
New Orleans District Office (NOL-DO)
6/2/2004
66PCB99ULTRAVIOLET SCREEN/SUNSCREEN N.E.C.
118NOT LISTED
New Orleans District Office (NOL-DO)
6/2/2004
66PDB99ULTRAVIOLET SCREEN/SUNSCREEN N.E.C.
118NOT LISTED
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Laboratoire Bioderma's FDA import refusal history?

Laboratoire Bioderma (FEI: 3002679824) has 9 FDA import refusal record(s) in our database, spanning from 6/2/2004 to 7/23/2010.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Laboratoire Bioderma's FEI number is 3002679824.

What types of violations has Laboratoire Bioderma received?

Laboratoire Bioderma has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Laboratoire Bioderma come from?

All FDA import refusal data for Laboratoire Bioderma is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.